Oxidation and endothelial dysfunction biomarkers of atherosclerotic plaque instability. studies of the vascular wall and blood

Bulletin of Experimental Biology and Medicine

Volumn 153, Issue 3, 2012, Pages 331-335

  Ragino, Yu I ^a   Chernjavski, A M ^b   Polonskaya, Ya V ^a   Volko, A M ^b   Kashtanova, E V ^a   Tikhonov, A V ^a   Tcimbal, S Yu ^b  

^a ENERGY SYSTEMS INSTITUTE   (Russian Federation)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

Author keywords

Correlations; Endothelial dysfunction; Lipid biomarkers; Oxidative and antioxidant; Stable and unstable atherosclerotic plaques

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; ATHEROSCLEROTIC PLAQUE INSTABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HISTOLOGY; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN MODIFICATION; STABLE ANGINA PECTORIS;

EID: 85027927249     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-012-1708-6     Document Type: Article

References (15)

1. E. B. Men'shchikova, N. K. Zenkov, V. Z. Lankin, et al., Oxidative Stress: Abnormalities and Disease [in Russian], Novosibirsk (2008).
2. Yu. I. Ragino, V. A. Baum, Ya. V. Polonskaya, et al., Byull. Eksp. Biol. Med., 145, No. 4, 389-392 (2008).
3. Yu. I. Ragino, M. I. Voevoda, M. I. Dushkin, et al., Klin. Lab. Diagnost., No. 4, 11-15 (2005).
4. Yu. I. Ragino, Ya. V. Polonskaya, and E. V. Sadovskii, Ibid., No. 6, 13-17 (2007).
5. Yu. I. Ragino, A. M. Chernjavski, Ya. V. Polonskaya, et al., Byull. Eksp. Biol. Med., 144, No. 11, 500-503 (2007).
6. G. A. Bonaterra, S. Zugel, and R. Kinscherf, Curr. Mol. Med., 10, No. 2, 180-205 (2010).
7. J. P. Empana, F. Canoui-Poitrine, G. Luc, et al., Eur. Heart. J., 29, No. 16, 1966-1974 (2008).
8. Y. Gidron, H. Gilutz, R. Berger, and M. Huleihel, Cardiovasc. Res., 56, No. 1, 15-21 (2002).
9. H. Holschermann, H. Tillmanns, and C. Bode, Haemostaseologie, 26, No. 2, 99-103 (2006).
10. N. R. Madamanchi, Z. S. Hakim, and M. S. Runge, J. Thromb. Haemostas., 3, No. 2, 254-267 (2005).
11. P. K. Shah, High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy, ed. by L. M. Khachigian, New York (2005), pp. 1-19.
12. S. Stemme, B. Faber, J. Holm, et al., Proc. Natl. Acad. Sc. USA, 92, No. 9, 3893-3897 (1995).
13. R. Stocker and J. F. Keaney, Physiol. Rev., 84, No. 4, 1381- 1478 (2004).
14. R. Waksman and P. W. Seruys, Handbook of the Vulnerable Plaque, London (2004), pp. 1-48.
15. X. Wang and T. M. Connolly, Adv. Clin. Chem., 50, 1-22 (2010).